Correlation of cyclin D1 and E1 expression with bladder cancer presence, invasion, progression, and metastasis.

[1]  Yair Lotan,et al.  Lymphovascular Invasion Is Independently Associated With Overall Survival, Cause-Specific Survival, and Local and Distant Recurrence in Patients With Negative Lymph Nodes at Radical Cystectomy , 2005 .

[2]  B. Clurman,et al.  Cyclin E in normal and neoplastic cell cycles , 2005, Oncogene.

[3]  T. A. Serel,et al.  Comparison of WHO 1973, WHO/ISUP 1998, WHO 1999 Grade and Combined Scoring Systems in Evaluation of Bladder Carcinoma , 2004, Urologia Internationalis.

[4]  A. Lopez‐Beltran,et al.  Prognostic Factors in Survival of Patients With Stage Ta and T1 Bladder Urothelial Tumors , 2004 .

[5]  R. Montironi,et al.  Prognostic factors in survival of patients with stage Ta and T1 bladder urothelial tumors: the role of G1-S modulators (p53, p21Waf1, p27Kip1, cyclin D1, and cyclin D3), proliferation index, and clinicopathologic parameters. , 2004, American journal of clinical pathology.

[6]  E. Ioachim,et al.  Expression Patterns of Cyclins D1, E and Cyclin-Dependent Kinase Inhibitors p21(Waf1/Cip1) and p27(Kip1) in Urothelial Carcinoma: Correlation with Other Cell-Cycle-Related Proteins (Rb, p53, Ki-67 and PCNA) and Clinicopathological Features , 2004, Urologia internationalis.

[7]  S. Groshen,et al.  Combined effects of p53, p21, and pRb expression in the progression of bladder transitional cell carcinoma. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  S. Shariat,et al.  p53, p21, pRB, and p16 expression predict clinical outcome in cystectomy with bladder cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  J. Kononen,et al.  Cyclin E overexpression and amplification in human tumours , 2003, The Journal of pathology.

[10]  S. Shariat,et al.  Association of p53 and p21 expression with clinical outcome in patients with carcinoma in situ of the urinary bladder. , 2003, Urology.

[11]  G. Landberg,et al.  The cyclin D1 high and cyclin E high subgroups of breast cancer: separate pathways in tumorogenesis based on pattern of genetic aberrations and inactivation of the pRb node , 2002, Oncogene.

[12]  A. Cittadini,et al.  Cyclin D1 expression in papillary superficial bladder cancer: Its association with other cell cycle‐associated proteins, cell proliferation and clinical outcome , 2002, International journal of cancer.

[13]  Y. Ito,et al.  Decreasing of p27Kip1 and cyclin E protein levels is associated with progression from superficial into invasive bladder cancer , 2001, British Journal of Cancer.

[14]  C. Cordon-Cardo,et al.  Intranuclear compartmentalization of cyclin E during the cell cycle: disruption of the nucleoplasm-nucleolar shuttling of cyclin E in bladder cancer. , 2001, Cancer research.

[15]  T. Wheeler,et al.  Prognostic value of P53 nuclear accumulation and histopathologic features in T1 transitional cell carcinoma of the urinary bladder. , 2000, Urology.

[16]  T Hardmeier,et al.  High-throughput tissue microarray analysis of cyclin E gene amplification and overexpression in urinary bladder cancer. , 2000, The American journal of pathology.

[17]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[18]  S. Reed,et al.  Deregulated cyclin E induces chromosome instability , 1999, Nature.

[19]  James M. Roberts,et al.  CDK inhibitors: positive and negative regulators of G1-phase progression. , 1999, Genes & development.

[20]  R. Kratzke,et al.  G1 checkpoint protein and p53 abnormalities occur in most invasive transitional cell carcinomas of the urinary bladder , 1999, British Journal of Cancer.

[21]  A. Borkowski,et al.  Loss of cell cycle regulators p27(Kip1) and cyclin E in transitional cell carcinoma of the bladder correlates with tumor grade and patient survival. , 1999, The American journal of pathology.

[22]  B. Czerniak,et al.  Level of retinoblastoma protein expression correlates with p16 (MTS-1/INK4A/CDKN2) status in bladder cancer , 1999, Oncogene.

[23]  C. Cordon-Cardo,et al.  p53 mutations in human bladder cancer: Genotypic versus phenotypic patterns , 1994, International journal of cancer.

[24]  S. Groshen,et al.  p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer. , 1993, The American journal of pathology.

[25]  S. Shurtleff,et al.  Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. , 1993, Genes & development.

[26]  James M. Roberts,et al.  Cyclin-dependent regulation of G1 in mammalian fibroblasts. , 1993, Science.